Cellular Therapy for Disc Degeneration Angiogenesis

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for lower back pain associated with disc degeneration do not address the underlying cause and often lead to incomplete recovery, as they focus on end-stage manifestations rather than altering the disease process, and existing methods do not effectively prevent the progression of disc degeneration.

Innovation Solution

Administration of cells capable of stimulating angiogenesis and anti-inflammatory activities, such as CD34+ bone marrow-derived cells, mesenchymal stem cells, and other cell types, to promote blood vessel formation and reduce inflammation in the lumbar region, thereby addressing the root cause of disc degeneration and pain.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments for lower back pain are administered, then pain relief may be achieved temporarily, but the underlying disc degeneration progresses and recovery is incomplete

Engineering Contradiction:
Improveeffectiveness of treatmentVSAvoiddisc degeneration progression
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies this principle by utilizing the body's natural inflammatory response and angiogenic pathways - processes that are typically associated with tissue damage and disease progression - and redirecting them toward beneficial outcomes. Specifically, the composition leverages inflammatory mediators and growth factors to stimulate angiogenesis (new blood vessel formation) and tissue regeneration in the degenerated disc, converting the harmful inflammatory process into a regenerative one that addresses the root cause of disc degeneration rather than merely masking symptoms

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent employs preliminary action by administering a composition that proactively stimulates angiogenesis and tissue regeneration before significant structural damage occurs. The composition contains agents that preemptively promote blood vessel formation and cellular repair mechanisms in the disc tissue, addressing the degenerative process at an earlier stage and preventing further progression rather than waiting for end-stage manifestations

Inventive Principle:
Principle #10Preliminary action

2Ease of operation

If treatments focus on end-stage manifestations of disc degeneration, then symptomatic relief may be provided, but the disease process is not altered and progression continues

Engineering Contradiction:
Improvesymptomatic treatment simplicityVSAvoiddisease modification capability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent transforms the approach from merely treating symptoms to converting the pathological processes into beneficial ones. By using inflammatory mediators and growth factors to stimulate angiogenesis and tissue regeneration, the treatment addresses the underlying disease mechanism rather than just end-stage symptoms, thereby modifying the disease course while maintaining operational feasibility through a single composition administration

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances perfusion to the degenerated disc area, accelerates healing, and reduces pain by stimulating angiogenesis and inhibiting inflammatory responses, offering a regenerative treatment for lower back pain that addresses the underlying cause of disc degeneration.

Implementation Method 1

Administration of cells capable of stimulating angiogenesis and anti-inflammatory activities, such as CD34+ bone marrow-derived cells, mesenchymal stem cells, and other cell types, to promote blood vessel formation

Methodology Applied
Scientific EffectAngiogenesis:

Implementation Method 2

Administration of cells capable of stimulating angiogenesis and anti-inflammatory activities, such as CD34+ bone marrow-derived cells, mesenchymal stem cells, and other cell types, to promote blood vessel formation and reduce inflammation in the lumbar region

Methodology Applied
Scientific EffectAnti-inflammatory activity:

Implementation Method 3

This approach enhances perfusion to the degenerated disc area, accelerates healing, and reduces pain by stimulating angiogenesis and inhibiting inflammatory responses

Methodology Applied
Scientific EffectPerfusion:

Data Source

PatentUS9598673B2Treatment of disc degenerative disease
Publication Date: 2017.03.21 STEMSPINE INC

AI summary

Methods and compositions for treating or ameliorating lower back pain by administering an effective amount of one or more cell types, alone, and/or in combination with a matrix, and/or in combination with growth factors, in order to stimulate lumbar angiogenesis, decrease inflammation, and stimulating regeneration.